PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture
Published in Breast Cancer Research
IntroductionEpithelial tumors, including breast cancer, are being identified and treated at earlier stages of tumor development because of technological advances in screening and detection methods. It is likely that early-stage epithelial tumors, such as mammary ductal carcinoma in situ (DCIS), will be amenable to new and more efficacious diagnosti...
